150 results
Page 2 of 8
8-K
EX-10.1
37v6dmtzi2o6ywp5y
10 Nov 21
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
4:12pm
8-K
EX-10.1
ip4h6utsodujo97z5
2 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
nuphyw4fu9ury
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
xm1cj2n3fuzircij
9 Feb 21
Termination of a Material Definitive Agreement
4:59pm
8-K
EX-10.1
llawqydn10b kp14y
26 Jan 21
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.1
1ue96g ltp72pvw2q
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
8-K
EX-10.3
doxix
28 Dec 20
Entry into a Material Definitive Agreement
6:15am
8-K
EX-10.1
autg pkfzbx0
28 Dec 20
Entry into a Material Definitive Agreement
6:15am
8-K
EX-10.2
20dpmy
28 Dec 20
Entry into a Material Definitive Agreement
6:15am
8-K
EX-10.1
wk9 9oz22crqdi
21 Dec 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
bfkk8g
17 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-10.1
rsp 8p4bjobuy212
24 Jun 20
Other Events
4:13pm
8-K
EX-10.1
y0s1teo7ki gkvge
18 Feb 20
Entry into a Material Definitive Agreement
6:39am